Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

More articles from Editorial

  • You have access
    The evolution of Epstein-Barr virus detection in nasopharyngeal carcinoma
    You Quan Li, Ni Sann Khin and Melvin L.K. Chua
    Cancer Biology & Medicine February 2018, 15 (1) 1-5; DOI: https://doi.org/10.20892/j.issn.2095-3941.2017.0176
  • You have access
    A race to uncover a panoramic view of primary liver cancer
    Ruidong Xue, Jing Li, Fan Bai, Xinwei Wang, Junfang Ji and Yinying Lu
    Cancer Biology & Medicine November 2017, 14 (4) 335-340; DOI: https://doi.org/10.20892/j.issn.2095-3941.2017.0112
  • You have access
    The ascent of immune checkpoint inhibitors: is the understudy ready for a leading role?
    Amy L. Cummings and Edward B. Garon
    Cancer Biology & Medicine November 2017, 14 (4) 341-347; DOI: https://doi.org/10.20892/j.issn.2095-3941.2017.0090
  • You have access
    The next generation of cancer management
    Wayne W. Grody
    Cancer Biology & Medicine March 2016, 13 (1) 1-2; DOI: https://doi.org/10.28092/j.issn.2095-3941.2016.0027
  • You have access
    Advances in cancer nanomedicine
    Lin-Tao Cai and Zong-Hai Sheng
    Cancer Biology & Medicine September 2015, 12 (3) 141-142; DOI: https://doi.org/10.7497/j.issn.2095-3941.2015.0049
  • You have access
    PD-L1 expression associated with better response to EGFR tyrosine kinase inhibitors
    Rafael Rosell and Ramón Palmero
    Cancer Biology & Medicine June 2015, 12 (2) 71-73; DOI: https://doi.org/10.7497/j.issn.2095-3941.2015.0026
  • You have access
    Tumor immune microenvironment characterization and response to anti-PD-1 therapy
    Mariacarmela Santarpia and Niki Karachaliou
    Cancer Biology & Medicine June 2015, 12 (2) 74-78; DOI: https://doi.org/10.7497/j.issn.2095-3941.2015.0022

Pages

  • Previous
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire